Get the Stockscreener App
1.74
4.13%
-0.075
After Hours:
1.77
0.03
+1.72%
Vor Biopharma Inc stock is traded at $1.74, with a volume of 3.40M.
It is down -4.13% in the last 24 hours and up +4.82% over the past month.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
See More
Previous Close:
$1.815
Open:
$1.8
24h Volume:
3.40M
Relative Volume:
0.20
Market Cap:
$220.43M
Revenue:
-
Net Income/Loss:
$-112.46M
P/E Ratio:
-1.061
EPS:
-1.64
Net Cash Flow:
$-99.89M
1W Performance:
-11.22%
1M Performance:
+4.82%
6M Performance:
+99.54%
1Y Performance:
+65.71%
1-Day Range:
$1.73
$1.87
1-Week Range:
$1.73
$2.03
52-Week Range:
$0.1311
$3.29
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma Inc
Sector
Industry
Phone
617-655-6580
Address
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Compare VOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
1.74 | 228.03M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-26-22 | Initiated | Wedbush | Outperform |
| Apr-27-22 | Initiated | Goldman | Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-21 | Initiated | Robert W. Baird | Outperform |
| Dec-02-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Mar-03-21 | Initiated | Evercore ISI | Outperform |
| Mar-02-21 | Initiated | Goldman | Sell |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Vor Biopharma Inc Stock (VOR) Latest News
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 464,421 Shares of Stock - MarketBeat
Reprogrammed Interchange Llc Sells 449,226 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Reprogrammed Interchange Llc Sells 350,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Clinical-Stage Biotech Vor Bio to Showcase Autoimmune Disease Pipeline at Stifel 2025 Virtual Forum - Stock Titan
139,600 Shares in Vor Biopharma Inc. $VOR Acquired by OMERS ADMINISTRATION Corp - MarketBeat
Vor Biopharma (VOR) 10% owners sell $2.46 million in stock - Investing.com
VOR SEC FilingsVor Biopharma Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully - Yahoo Finance
Screener Results Flag Vor Biopharma Inc. as OversoldCPI Data & Weekly Setup with ROI Potential - 뉴스영
How to integrate Vor Biopharma Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Risk vs reward if holding onto Vor Biopharma Inc.Gap Up & High Accuracy Investment Signals - Newser
Is Vor Biopharma Inc. likely to announce a buybackMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک
Is Vor Biopharma Inc.’s growth already priced inJuly 2025 Gainers & Safe Entry Momentum Stock Tips - خودرو بانک
Vor Biopharma (VOR) 10% owners sell shares worth $2.77 million By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owners sell shares worth $2.77 million - Investing.com
What is Vor Biopharma Inc. s 5 year growth outlookInsider Buying & Fast Exit Strategy with Risk Control - خودرو بانک
How cyclical is Vor Biopharma Inc.’s revenue streamJuly 2025 Trends & Accurate Entry and Exit Point Alerts - خودرو بانک
Measuring Vor Biopharma Inc.’s beta against major indicesStop Loss & Momentum Based Trading Signals - Newser
What’s next for Vor Biopharma Inc. stock priceQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Sector ETF performance correlation with Vor Biopharma Inc.Earnings Summary Report & Long-Term Growth Plans - Newser
Can Vor Biopharma Inc. lead its sector in growthPortfolio Value Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Vor Biopharma shares rise 2.59% premarket after Connect Biopharma's Nasdaq listing. - AInvest
Is Vor Biopharma Inc. gaining market shareSwing Trade & Fast Gaining Stock Strategy Reports - خودرو بانک
Does Vor Biopharma Inc. fit your quant trading modelWeekly Trade Review & Capital Efficient Trading Techniques - Newser
Quantitative breakdown of Vor Biopharma Inc. recent moveOptions Play & High Win Rate Trade Tips - Newser
Is Vor Biopharma Inc. stock overvalued or fairly priced2025 Major Catalysts & Weekly High Return Stock Opportunities - خودرو بانک
Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns - Investing.com Nigeria
Custom strategy builders for tracking Vor Biopharma Inc.2025 Big Picture & Verified Entry Point Signals - Newser
What data driven models say about Vor Biopharma Inc.’s futureShare Buyback & Stock Portfolio Risk Management - Newser
Real time social sentiment graph for Vor Biopharma Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Price momentum metrics for Vor Biopharma Inc. explained2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Is Vor Biopharma Inc. stock a good pick for beginnersJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - خودرو بانک
Vor Biopharma Inc. stock trend outlook and recovery pathMarket Weekly Review & Long-Term Safe Investment Plans - Newser
Using data filters to optimize entry into Vor Biopharma Inc.July 2025 Drop Watch & Verified Technical Trade Signals - Newser
Applying chart zones and confluence areas to Vor Biopharma Inc.Bond Market & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Vor Biopharma Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Can Vor Biopharma Inc. grow without external fundingJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Using flow based indicators on Vor Biopharma Inc.Dividend Hike & Safe Capital Growth Stock Tips - Newser
Trend analysis for Vor Biopharma Inc. this weekEarnings Miss & Long-Term Growth Stock Strategies - Newser
Multi factor analysis applied to Vor Biopharma Inc.July 2025 Earnings & Weekly Top Gainers Trade List - Newser
Does Vor Biopharma Inc. show high probability of reboundJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Vor Biopharma Inc Stock (VOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):